Off-label use of rituximab in patients with different types of nephropathies in a tertiary hospital: A retrospective study

被引：0
|
作者：
Sans Pola, Carla [1 ,2 ,3 ]
Agusti Escasany, Antonia [1 ,2 ,3 ]
Bosch Gil, Josep Angel [1 ,2 ]
Agraz Pamplona, Irene [1 ]
Alerany Pardo, Carmen [1 ]
Danes Carreras, Immaculada [1 ,2 ,3 ]
机构：
[1] Vall dHebron Hosp Univ, Barcelona, Spain
[2] Univ Autonoma Barcelona, Barcelona, Spain
[3] Vall dHebron Inst Recerca, Barcelona, Spain
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2022年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
11
引用
收藏
页码：16 / 16
页数：1
相关论文
共 50 条
  • [41] RETROSPECTIVE DATA COLLECTION OF OFF-LABEL USE OF RITUXIMAB IN RENAL DISEASE AND VASCULITIDES IN THE TASMANIAN HEALTH SERVICE
    Tan, P.
    De Little, T.
    Kirkland, G.
    Jose, M.
    Jeffs, L.
    Yu, R.
    Yew, S.
    NEPHROLOGY, 2016, 21 : 56 - 56
  • [42] Off-label antibiotic use among paediatric in-patients: a mixed-method prospective study at a tertiary hospital in southwestern Uganda
    Obura, Bonniface
    Alele, Paul E.
    Obua, Celestino
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (03) : 637 - 644
  • [43] Rituximab/methylprednisoloneVarious toxicities following off-label use of rituximab: 6 case reports
    Reactions Weekly, 2016, 1602 (1) : 215 - 215
  • [44] Off-label antibiotic use among paediatric in-patients: a mixed-method prospective study at a tertiary hospital in southwestern Uganda
    Bonniface Obura
    Paul E. Alele
    Celestino Obua
    International Journal of Clinical Pharmacy, 2021, 43 : 637 - 644
  • [45] Off-label use of propranolol hydrochloride in hospital pharmacy
    Mignini, Irma
    Stancari, Alessandra
    Bersani, Germana
    Maselli, Silvia
    Guarguaglini, Anna Maria
    Puggioli, Cristina
    PHARMACY WORLD & SCIENCE, 2010, 32 (02): : 292 - 293
  • [46] Unlicensed and off-label drug use in paediatrics in a mother-child tertiary care hospital
    Corny, Jennifer
    Bailey, Benoit
    Lebel, Denis
    Bussieres, Jean-Francois
    PAEDIATRICS & CHILD HEALTH, 2016, 21 (02) : 83 - 87
  • [47] RituximabPneumonia and hypogammaglobulinaemia following off-label use of rituximab: case report
    Reactions Weekly, 2021, 1841 (1) : 213 - 213
  • [48] Off-Label Use Of Rituximab For Systemic Lupus Erythematosus in Europe: Limited Use Mostly In Refractory Patients
    van Vollenhoven, Ronald F.
    Mild, Melinda
    Doria, Andrea
    Doerner, T.
    Ferraccioli, Gianfranco
    Houssiau, Frederic
    Huizinga, T. W. J.
    Isenberg, David A.
    Kovacs, Laszlo
    Ruiz-Irastorza, Guillermo
    Squatrito, Danilo
    Voskuyl, Alexandre
    Mosca, Marta
    Sebastiani, G. D.
    Inanc, Murat
    Szuecs, Gabriella
    Jacobsen, Soren
    Castro, A.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S684 - S684
  • [49] Off-label use of rituximab in systemic lupus erythematosus: a systematic review
    Murray, Eleanor
    Perry, Martin
    CLINICAL RHEUMATOLOGY, 2010, 29 (07) : 707 - 716
  • [50] Off-label use of rituximab for dermatologic conditions: A single center review
    Porter, Emma
    Finnegan, Paula
    Long, Amy
    Bourke, John F.
    Murphy, Michelle
    O'Connor, Cathal
    JEADV CLINICAL PRACTICE, 2024, 3 (04): : 1195 - 1199
12345